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Summary Misonidazole (MISO) potentiates the cell killing effect of certain chemotherapy agents, but only
under hypoxic conditions. The purpose of the present study was to define the range of oxygen concentrations
over which chemosensitization by MISO takes place using mammalian cells cultured in vitro, and to compare
this with the oxygen levels required for radiosensitization. V-79 hamster cells, attached to permanox dishes,
were gassed with known concentrations of oxygen (<10 to 200,000ppm) and treated with 1 and 5 mM MISO
for 4h previous to exposure to the chemotherapy agent, melphalan. In a parallel series of experiments, under
the same gassing conditions, cells were irradiated with graded doses of X-rays at various oxygen
concentrations. The K factor i.e. the oxygen concentration which defined half the maximum effect was found
to be -4776ppm for radiosensitization and -400ppm for chemosensitization by MISO. It is evident that a
significantly more stringent level of hypoxia is required for chemosensitization by MISO to take place than
for radiosensitization.
The effect of molecular oxygen on the sensitivity of
cells and tissues to radiation has been of major
interest to radiobiologists and radiation therapists
alike, since its importance was fully realized several
decades ago by Thomlinson and Gray (1955). In
transplanted tumours in small rodents, exposed to
single large doses of radiation, tumour control is
certainly governed by the presence of foci of
chronically hypoxic cells which are intransigent to
killing by X-rays and constitute a focus for the
regrowth of the tumour. To what extent the same is
true in human tumours, treated with multiple small
doses of radiation, has been the subject of
speculation for many years. A number of
innovative strategies have been introduced in an
attempt to decrease the differential radiosensitivity
between oxygenated and hypoxic cells. The first of
these was the introduction of hyperbarbic oxygen in
an attempt to cause oxygen to diffuse to regions
otherwise hypoxic; an alternative effort was the use
of more densely inonizing radiations for which the
presence or absence of molecular oxygen has a
smaller influence on the degree of cell kill; the most
recent attempt is the development of sensitizers that
are electron affinic and mimic oxygen and thus
sensitize hypoxic cells without having any
significant influence on aerated cells (Adams &
Dewey, 1963).
The realization that hypoxia may have an influence
on the success of chemotherapy is of much
more recent date (Roizin-Towle & Hall, 1978;
Kennedy et al., 1980). Sensitizers developed initially
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to increase the sensitivity of hypoxic cells to
radiation have been found also to increase the
sensitivity of cells to chemotherapy agents (Roizin-
Towle & Hall, 1981). Chemosensitization however,
requires that the cells be exposed for prolonged
periods of time to the sensitizing drugs, and at least
in vitro hypoxia appears to be an absolute
requirement. In transplantable tumours in small
laboratory rodents, sensitization of cells to
alkylating agents by the use of misonidazole has a
magnitude which appears to be much greater than
can be accounted for on the basis of the known
proportion of radiobiologically hypoxic cells. The
realization that selective killing of hypoxic cells by
MISO may not be the sole factor in chemo-
sensitization was suggested by earlier studies in vivo
(Sieman, 1982; Rose et al., 1980; Clement et al.,
1980). The experiments reported in this paper were
designed to investigate the role of oxygen in chemo-
sensitization and to compare on an equal basis the
K factor, that is the concentration of oxygen
characteristic of a sensitivity half way between
complete anoxia and full oxygenation, for chemo-
sensitization and radiosensitization.
Materials and methods
V-79 hamster fibroblast cells in exponential phase
of growth were used for these experiments. The
cells were maintained in F-10 medium,
supplemented with 10% foetal calf serum,
penicillin/streptomycin and 1% glutamine. Cells
were plated onto permanox dishes (Lux Corp.) the
day before an experiment at numbers estimated to
give 100-200 surviving colonies per treatment dose.
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The equipment used was designed and fabricated
in our own machine shop. Sensitization of cells
by MISO to lethality by melphalan, and sensi-
tization of V-79 cells to 30kVp X-rays was
studied as a function of varying concentrations of
oxygen. In both series of experiments, (chemo-
sensitization or radiosensitization) the cells were
treated under identical conditions so that the K
curves could be compared directly. The advantages
of this system over other techniques (such as
spinner culture) are that cells remain attached
throughout the entire procedure, avoiding clumping
and mechanical shearing of the cells by a stirring
apparatus. It also avoids several centrifugation
procedures needed to remove sensitizing drugs
which results in cell loss. The nature of the 'pre-
incubation' studies require extended periods of
time, and this system allows not only sufficient time
for equilibrium of gas with medium, but allows
cells to be irradiated or treated with drug at a
minimum of disturbance. Cells were plated at a
density of 200 to 5,000 per dish depending on the
expected level of survival.
The apparatus consisted of two rectangular
boxes, each of which could accommodate 16
permanox culture dishes (Miles Labs., Naperville,
Illinois). The containment boxes were connected to
each other by Tygon tubing and were further
connected by standard fittings to certified gas
tanks. Gas was humidified before flowing through
the lucite boxes, and a water trap was connected at
the exhaust end of the system to prevent gas flow-
back. A Thermox IA Oxygen Analyzer (Ametex,
Pittsburg, Pennsylvania) was used to check the
oxygen content of the gas tanks and to measure the
02 content of the gas effluent after its route
through the apparatus. The flow-rate was 8 1min ',
compared with a total volume of the containers of
0.1 1.
For any given experiment, dishes containing cells
were placed in the lucite boxes on a metal frame
attached to a mechanical linkage that rocked the
boxes at 6rpm in a 37.5°C water bath. This was to
ensure gas equilibration with the 3ml medium
overlying the cells. To speed equilibration, the lucite
boxes were alternately gassed and evacuated for 1 h.
Once the desired level of hypoxia was achieved, the
rocking was discontinued, but the gas flow was
maintained through the prolonged periods of pre-
incubation with MISO.
For the chemosensitization experiments, half the
dishes contained either 1 or 5mM MISO, while the
others served as the untreated control. Cells were
pretreated at a given 02 concentration, with or
without MISO, for a total of 4h at 37.5°. After the
preincubation period four untreated control dishes
were given a test dose of X-rays, and the resulting
surviving fraction compared with previous radio-
sensitization experiments to serve as an internal
check that there were no air leaks in the system.
Following the preincubation treatment, the lucite
boxes containing the dishes were removed from the
water bath, the cells were washed free of MISO and
a 1 h exposure of cells to graded doses of L-PAM
at 37.5°C begun. At the completion of this drug
exposure, the dishes were once again washed free of
drug, replenished with fresh medium, and incubated
for 7 days at 37.5°C to allow for colony formation.
The MISO cytotoxicity in each preincubation
exposure, and MISO enhancement ratio for
melphalan killing were calculated from the survival
curves generated by each experiment. A whole
series of experiments were performed for 02
concentrations ranging from <10 to 200,000 ppm
02. Dos for control and MISO pretreated cells were
used to estimate the MISO sensitivity ratio, and
ultimately the K factor for the preincubation effect.
Radiosensitization experiments involved the same
basic procedure except that at the end of the
gassing period, the dishes were irradiated in situ
with'the gas mixture still flowing, and no MISO
was used in the pretreatment. An aerated survival
curve was performed in each experiment and the
OER and the sensitization factor evaluated each
time. Irradiations were performed with a Sieman's
Stabilipan X-ray therapy machine, operating at
300kVp 30mA with added filtration of 0.2mm
copper and 0.5mm aluminium. The dose rate at the
position occupied by the cells was computed to be
3.6Gymin-1. Survival curves generated by
exposure of cells to a whole range of 02
concentrations produced data necessary to calculate
the K value for radiosensitization.
Results
Data from a representative experiment illustrating
the dependence of radiosensitivity on oxygen
concentration are shown in Figure 1; the series of
dose response curves were derived for cells
irradiated under various oxygen concentrations
using the permanox dishes and apparatus described
above. A series of survival curves were generated in
this fashion with relative sensitivity defined as the
inverse of the Dog where Do is calculated in the
usual way from the slopes of the exponential tails
of the shouldered survival curves using the Pike-
Alper computer fit (Pike & Alper, 1964).
Evaluation of all test oxygen concentrations in one
day was impossible so that data points in Figure 2
represent the accumulated results of several
experiments where data was eliminated unless it
was within 95% confidence limits.OXYGEN DEPENDENCE FOR CHEMOSENSITIZATION 921
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Figure 1 Radiation survival curves of V-79 cells as a
function of oxygen concentration.
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Figure 2 Relative sensitivity as a function of oxygen
concentration for cells treated with 300kVp X-rays.
The K value of this curve plotted on a linear-linear
plot was 4776 ppm+ 100 ppm 02.
Data are plotted on a linear-linear scale in a
similar fashion to that used by others in
documenting this effect (Howard-Flanders & Alper,
1957; Held et al., 1984; Shenoy et al., 1975). Data
were fitted to an equation relating a given
concentration of oxygen to relative radiosensitivity
based on a formula by Alper and Howard-Flanders
(1956) as shown in Equation 1.
r =(m[02] +K)/([02] +K) (1)
It was semi-empirically derived by Alper and
Howard-Flanders from their equation relating a
given partial pressure of oxygen to the extent of
radiosensitization in bacterial cells where r was the
sensitivity at a particular concentration or
particular pressure of oxygen [02], relative to that
under anoxia and m was the OER or oxygen
enhancement ratio. Sensitivity (r) was defined as
the inverse of the dose required to give an average
of one lethal event per cell (Do 1), Do being
calculated in the usual way from the slope of the
exponential tails of the shouldered survival curves.
The term we used to represent radiosensitivity (r)
was proportional to the inverse of the Do of the
survival curve and was assigned a value of 1 for
anoxia and a maximum r value of 3.7 for the
maximum aerated response. The break in the
survival curve between 5,000 and 200,000 ppm 02 iS
shown this way as estimations of r were not made
at these oxygen levels.
Howard-Flanders and Alper both showed that
Equation 1 could be derived theoretically and may
be rewritten as:
(r
-1)/(m
-r)
=[02]/K. (2)
Our radiation data were well fitted by the equations
given above. A K value, or sensitivity half way
between anoxia and air, occurred at a
concentration of about 4776+ 100ppm or 0.47% of
oxygen. This value was similar to other values for
mammalian cells cited in the literature. The
enhancement ratio for chemosensitization was
calculated as the ratio of drug dosages of control to
preincubated cells that produced a survival level of
10%. The standard errors on the points shown in
Figure 2 represent pooling of data at the same
concentration for several repeat experiments.
Figure 3 illustrates that chemosensitization of
hamster cells by MISO is at a maximum when
oxygen levels are <10ppm. This figure shows
pooled data from two experiments demonstrating
the sensitizing effect of MISO (1 and 5mM) on
cellular toxicity to melphalan. Chemosensitization
of cells by MISO in contrast to radiosensitization,
is defined by very low levels of oxygen.
Pretreatment of cells at a range of oxygen
concentrations generated a series of survival curves
which were computer-filled to the Pike-Alper
equation that was also used to fit the radiation
survival curves. We defined a MISO sensitivity
ratio (r) in a fashion similar to the way we
calculated r for radiosensitivity. A series of survival
curves derived from cells exposed to melphalan
were generated at a wide range of [02]
concentrations as illustrated in Figure 3. Dos were
calculated from each MISO-pretreated and control922 L. ROIZIN-TOWLE et al.
determined according to the equati
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ion functional at levels of MISO that are non-cytotoxic,
although the drug enhancement factors are
substantially reduced especially in the case of 1 mm
MISO (i.e. sensitivity ratio of 1.4) which is most
(4) comparable to drug dosages achievable in a clinical
situation.
Discussion
The combined use of an hypoxic cell sensitizer with
a cancer therapeutic agent to enhance the killing of
hypoxic cells resistant to antineoplastic agents is a
relatively recent idea (Roizin-Towle & Hall, 1978;
Rose et al., 1980), but one which has questioned
the importance of oxygen as a modifier of drug
toxicity. Focussing on the importance of oxygen the
K factor for MISO chemosensitization of melphalan
and the K factor for radiosensitization were
compared on an equal basis. The objective was to
determine whether chemosensitization was
functional at intermediate levels of oxygen, and at
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Figure 3 Chemosensitization of melphalan-treated
cells by preincubation with two doses of MISO (1 and
5 mM) at a gas concentration of < 10 ppm 02.
Figure 4 summarizes the results of these pooled
experiments where a ratio of 1 indicated no effect
and 5 was the maximum enhancement ratio seen
with preincubation of cells with 5mM MISO. These
ratios were corrected for cytotoxicity, if any, in the
preincubation exposures. Calculations of K factors
for chemosensitization of MISO using Equations 2
and 3 did not yield the values we estimated
experimentally from the data in Figure 4.
Estimating the K factor as that value which yields
half the maximal effect (i.e. (m + 1)/2 yielded a K
value between 300 and 500 ppm of 02 This is a
reasonably good estimate for the oxygen
concentration required to reduce chemosensitization
by 1/2 given the stringent conditions and care with
which these experiments were performed. The close
association between cytotoxicity in preincubation
exposures and chemosensitization is illustrated in
Figure 5, where cytotoxicity of 1 and 5mM MISO is
looked at as a function of oxygen concentration.
Measurable cytotoxicity with these drug pre-
treatments was only seen at oxygen levels below
200 ppm. No cytotoxicity was seen for 1 mm MISO
at values of 02 of 200 ppm and above, and only
10% for the 5mM pretreatment dose. This implies
that half the chemosensitization effect is still
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Figure 4 Oxygen dependence of chemosensitization of
cells by MISO illustrating the narrow range of oxygen
levels (300-500ppm 02) at which half the pre-
incubation effect is lost.
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Figure 5 The cytotoxicity of MISO (1 and 5mM) as a
function of oxygen concentration.
curve and r
below:
1.0
c
0
C.)
C 101
102
6- %4-
CD o-2
I 1OXYGEN DEPENDENCE FOR CHEMOSENSITIZATION 923
MISO concentrations likely to be found in human
tumours.
The results of this chemosensitization study
indicated that therapeutic effectiveness in vivo might
only be expected in those tumours with a significant
hypoxic component with cells at very low oxygen
concentration. The narrow window at which
oxygen potentiated MISO toxicity and chemo-
sensitization implied that other processes occurring
in tumour and normal tissue may be at least as
important as hypoxia in contributing to chemo-
sensitization in vivo. A direct comparison of the
oxygen dependence for MISO toxicity and chemo-
potentiation of melphalan in Figures 4 and 5
underlies this point. The K value for chemo-
sensitization, based on the data in Figure 4, was
between 300 and 500ppm of 02 for both 1 and
5mm concentrations of MISO. With the exception
of the data in Figure 3 where preincubation of cells
with 5mM MISO at <l0ppm of 02 resulted in
moderate toxicity (cell surviving fraction of 55%),
there was no detectable toxicity of MISO with 02
concentrations above 200ppm - cytotoxicity and
chemosensitization are inevitably associated. This
means that, for these series of experiments, the
chemosensitizing potential of MISO was essentially
measured independent of cellular toxicity. Clinical
manifestation of peripheral neuropathies are
associated with MISO dosage, so there is little
point in scrutinizing chemotherapeutic effectiveness
at cytotoxic drugs levels. The raw data from this
and previous studies (Roizin-Towle, 1982; Roizin-
Towle et al., 1984; Mulcahey, 1984; Roizin-Towle,
1985) show that the magnitude of' chemo-
sensitization in vitro is directly linked to
cytotoxicity which functions most efficiently at
extremely low levels of hypoxia (<1Oppm of 02)
and at doses of MISO higher than those that are
achievable clinically. This is in sharp contrast to the
data for radiosensitization in Figures 2 and 4 where
the half maximal effect for radiosensitization
differed by an order of magnitude from chemo-
potentiation (i.e. 4776ppm for radiation and
400ppm for MISO). Clearly the two processes
differ fundamentally - the former primarily involves
a free-radical process whereas the latter is a
function of drug metabolism and cellular
physiology.
Biochemical studies in vitro (Chapman et al.,
1983; Koch, et al., 1984; Rauth et al., 1984) and
tumour models in vivo have shown that nitro-
reduction of MISO to a toxic species is associated
with its cellular binding and biological activity
(Sieman, 1982; Varghese et al., 1976). Other
variables independent of oxygen that contribute to
chemopotentiation includes hypoxia-mediated cell
membrane damage leading to enhanced oxidative
stress and damage to the Ca2+ membrane pump,
decreased levels of ATP and protein synthesis as
well as loss of endogenous cellular thiols (Roizin-
Towle et al., 1984, 1984; Hochacha, 1986). Cell
killing of human lung carcinoma cells by melphalan
is increased in the plateau versus the exponential
state due in part to the fact that glutathione levels
in the former can be lower by an order of
magnitude (Roizin-Towle, unpublished). Given a
tumour with low proliferative activity and a small
hypoxic component, for instance, MISO toxicity
may be minimal due to a futile drug metabolism in
an aerated environment, whereas, cytotoxicity by
melphalan would be favoured by a lowered thiol
status. These results indicate that the independent
action of the agents involved (i.e. sensitizer and
antineoplastic drug) in vivo are as much a reflection
of the drugs used as the physiological status of the
tumour being treated.
The results of this study indicated that chemo-
sensitization of melphalan by MISO in vitro
operates most efficiently at very low oxygen levels
(i.e. 300 to 500ppm). Chemopotentiation in vivo,
however, may be compartmentalized to areas of
tumours where the combined or independent action
of the agents is favoured by oxygen levels,
proliferative status and possibly other unknown
variables (Randhawa et al., 1985). Results of phase
I/II clinical trials of MISO with CCNU or
cyclophosphamide in malignant brain and renal cell
carcinoma indicated that certain tumours may in
fact be more responsive than others (Fulton et al.,
1985; Glover et al., 1985), but long term predictions
are still premature at the present. We are currently
screening a number of human-derived carcinoma
cell lines with this particular drug regime with the
hope of defining those carcinomas that may show a
more favourable response to this combination
therapy.
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